The South Korean Ministry of Drug and Food Safety has come under fire for its lax management after it mistakenly publicized the official approval of a new drug that was still undergoing review on the ministry’s website. On Wednesday, the Drug Ministry publicized on its website that it had granted approval to a new osteoporosis drug developed by Hanmi Pharmaceutical.